期刊文献+

乳腺癌组织中IGF-IR、SUSD3的表达及其临床意义 被引量:10

Expression of IGF-IR and SUSD3 in breast cancer and their clinical significance
下载PDF
导出
摘要 目的探讨胰岛素样生长因子-I受体(IGF-IR)和SUSD3在乳腺癌组织中的表达情况,分析两者与临床病理特征的关系及其两者间的相关性。方法采用Max VisionTM免疫组化法检测100例乳腺癌组织和对应癌旁组织中IGF-IR、SUSD3的表达,并分析其与乳腺癌临床病理特征的关系。结果 IGF-IR在乳腺癌和癌旁组织中的阳性表达率分别为86.0%和3.0%(P<0.05),SUSD3在乳腺癌和癌旁组织中的阳性表达率分别为78.0%和2.0%(P<0.05)。乳腺癌组织中IGF-IR和SUSD3的表达与ER水平和病理类型有关(P<0.05),而与年龄、HER-2表达、Ki-67表达和分期均无关(P>0.05)。IGF-IR和SUSD3在乳腺癌组织中的表达呈正相关(r=0.553,P<0.01)。结论 IGF-IR、SUSD3可能与乳腺癌的发生、发展有关,与ER联合检测对判断乳腺癌预后和指导术后辅助治疗有重要意义。 Objective To investigate the expression of insulin-like growth factor-I receptor ( IGF-IR) and sushi domain-con-taining protein 3 ( SUSD3) in breast cancer tissue, and analyze their relationship with clinical parameters and the correlation between the two proteins. Methods The expression of IGF-IR and SUSD3 in 100 cases of beast cancer tissues and the corresponding adjacent normal breast tissues after surgery was detected by immunohistochemical technique MaxVisionTM , and the relationship with clinical pathological features was further analyzed. Results The positive rate of IGF-IR protein was 86.0% in breast cancer tissues, higher than 3.0% in adjacent normal breast tissues(P&lt;0.05).The positive expression rate of SUSD3 protein was 78.0% in breast cancer tis-sues, higher than 2.0% in adjacent normal breast tissues( P&lt;0.05) . The expression of IGF-IR and SUSD3 was related to estrogen re-ceptor and pathological types ( P&lt;0.05) , but not with age, stage, the expression of HER-2 and Ki-67( P&gt;0. 05) . The expression of IGF-IR and SUSD3 in breast cancer tissue was positively related ( r=0.553, P&lt;0.01) . Conclusion The expression of IGF-IR and SUSD3 may be correlated to the occurrence and development of breast cancer. The combined detection of IGF-IR, SUSD3 and ER may play an important role in judging prognosis and guiding adjuvant therapy after surgery of breast cancer.
出处 《临床肿瘤学杂志》 CAS 2014年第4期303-306,共4页 Chinese Clinical Oncology
基金 江苏省第八批六大人才高峰项目(NO2011-WS-077)
  • 相关文献

参考文献12

  • 1So WK, Leung DY, Ho SS, et al. Associations between social sup- port, prevalent symptoms and health-related quality of life in Chi- nese women undergoing treatment for breast cancer: A cross-sec- tional study using structural equation modeling [ J ]. Eur J Oncol Nurs, 2012,12(10) : 1462-1476.
  • 2于正洪,姜恩泽,上官俊杰,陈龙邦.乳腺脂肪组织中芳香酶与乳腺癌的关系的研究进展[J].医学研究生学报,2013,26(12):1320-1325. 被引量:5
  • 3Abbasi S, Rasouli M, Nouri M, et al. Association of estrogen re- ceptor-α A908G (K303R) mutation with breast cancer risk[J]. Int J Clin Exp Med, 2013,6(1) :39-49.
  • 4Bulun SE, Chen D, Moy I, et al. Aromatase, breast cancer and obesity: a complex interaction [ J ]. Trends Endocrinol Metabo, 2012,23(2) :83-89.
  • 5Diaz-Cruz ES, Sugimoto Y, Gallicano GI, et al. Comparison of increased aromatase versus ERa in the generation of mammary hyperplasia and cancer[ J]. Cancer Res, 2011,71 (16) : 5477 -5487.
  • 6于正洪,姜恩泽,赵红,上官俊杰,王新星,吕镗锋,陈礼朋,陈龙邦.雌二醇和胰岛素样生长因子-Ⅰ诱导的胰岛素样生长因子-Ⅰ受体和雌激素受体间的作用研究[J].医学研究生学报,2013,26(9):907-911. 被引量:6
  • 7Surmacz E. Function of the IGF-I receptor in breast cancer[J].J Mammary Gland Biol Neoplasia, 2000,5 ( 1 ) : 95-105.
  • 8Yu Z, Gao W, Jiang E, et al. Interaction between IGF-IR and ER Induced by E2 and IGF-I [ J/OL]. PLoS One, 2013 [ 2014-01- 05]. http ://www.ncbi.nlm.nih. gov/pubmed/23704881.
  • 9Parris TZ, Danielsson A, Nemes S, et al.Clinical implications of gene dosage and gene expression patterns in diploid breast carci- noma [ J ]. Clin Cancer Res, 2010,16 ( 15 ) : 3860- 3874.
  • 10Casa AJ, Potter AS, Malik S, et aL Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical re- pressors of breast cancer growth [ J]. Breast Cancer Res Treat, 2012,132( 1 ) :61-73.

二级参考文献61

  • 1梁元姣,张慧明,郝群,徐艳,季爱华,胡娅莉.胰岛素样生长因子受体及雌激素受体在子宫内膜样腺癌中的表达及临床病理意义[J].医学研究生学报,2011,24(5):472-476. 被引量:6
  • 2Contois LW, Nugent DP, Caron JM, et al. Insulin-like growthfactor binding protein-4 differentially inhibits growth factor-in- duced angiogenesis[ J]. J Biol Chem, 2012, 287 ( 3 ) : 1779- 1789.
  • 3Fox EM, Miller TW, Balko JM, et al. A kinome-wide screen identifies the insulin/IGF- I receptor pathway as a mechanism of escape from hormone dependence in breast cancer [ J ]. Cancer Res, 2011, 71(21 ): 6773-6784.
  • 4Garcia-Segura LM, Ar6valo MA, Azcoitia I. Interactions of estra- diol and insulin-like growth factor- I signalling in the nervous system: new advances [ J ]. Prog Brain Res, 2010, 181 : 251- 272.
  • 5Casa A J, Potter AS, Malik S, et al. Estrogen and insulin-like growth factor- I ( IGF- I ) independently down-regulate critical repressors of breast cancer growth [J]. Breast Cancer Res Treat, 2012, 132(1) :61-73.
  • 6Bradley LM, Gierthy JF, Pentecost BT. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line [ J ]. J Steroid Bio- chem Mol Biol, 2008,109 ( 1-2 ) : 185-196.
  • 7Spink BC, Bennett JA, Pentecost BT, et al. Long-term estrogen exposure promote carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast [J]. Toxicol Appl Pharmacol, 2009, 240 (3) :355-366.
  • 8Felice DL, Unterman TG, Swanson SM, et al. Growth hormone activates ERK via EGFR, not IGF-IR, to potentiate estrogen-de- pendent breast cancer cell proliferation[ J]. Cancer Res, 2012, 2(8) : 538-545.
  • 9Bartella V, De Marco P, Malaguamera R, et al. New advances on the functional cross-talk between insulin-like growth factor- I and estrogen signaling in cancer[ J]. Cell Signal,2012, 24 (8) : 1515-1521.
  • 10Flegal KM,Carroll MD,Ogden CL,et al.Prevalence and trends in obesity among US adults,1999-2008[J].JAMA,2010,303(3):235-241.

共引文献7

同被引文献123

引证文献10

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部